20 (AIDX) Current Assets (2024 - 2026)

20 (AIDX) posted Current Assets of $4.7 million for Q1 2026, up 219.5% on a QoQ basis from $1.5 million in Q4 2025.

20 (AIDX) Current Assets (2024 - 2026) Analysis & Trends

20's Current Assets history runs 3 years deep, the most recent figure standing at $4.7 million for Q1 2026.

  • Quarterly Current Assets changed N/A year-over-year to $4.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.7 million (changed N/A YoY) and the FY2025 annual result came in at $1.5 million, down 27.68% from the prior year.
  • Current Assets was $4.7 million for Q1 2026 at 20, up from $1.5 million in the prior quarter.
  • Across five years, Current Assets topped out at $4.7 million in Q1 2026 and bottomed at $1.5 million in Q4 2025.
  • A 3-year average of $2.7 million and a median of $2.0 million in 2024 frame the typical range for Current Assets.
  • Peak annual rise in Current Assets reached 27.68% in 2025, while the deepest fall reached 27.68% in 2025.
  • 20's Current Assets stood at $2.0 million in 2024, then slipped by 27.68% to $1.5 million in 2025, then surged by 219.5% to $4.7 million in 2026.
  • Business Quant data shows AIDX's Current Assets at $4.7 million in Q1 2026, $1.5 million in Q4 2025, and $2.0 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 25.51 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 13.34 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 24.79 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 8.68 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 6.23 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 4.33 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 11.45 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 10.43 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 4.10 Bn
10 20 3.91 Mn -313,912.28 62,884.00 4.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.70 Mn
Dec 31, 2025 1.47 Mn
Dec 31, 2024 2.03 Mn